Related Experiment Video

Updated: May 3, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

Clive Kearon1, Elie A Akl

  • 1Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada; and.

Blood
|February 6, 2014
PubMed

Insights

Treatment duration for venous thromboembolism (VTE) typically lasts 3 months or indefinitely. Decisions balance recurrence risk, bleeding risk, and patient preference for optimal VTE management.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Medicine

Background:

  • Venous thromboembolism (VTE) treatment involves an initial active phase followed by secondary prevention.
  • Treatment duration for VTE is generally categorized into 3 months or indefinite anticoagulation.
  • The choice between stopping anticoagulation at 3 months or continuing indefinitely is critical for patient outcomes.

Purpose of the Study:

  • To outline the decision-making process for VTE treatment duration.
  • To identify factors influencing the choice between 3-month and indefinite anticoagulation.
  • To guide clinical practice in managing VTE based on recurrence and bleeding risks.

Main Methods:

  • Review of clinical guidelines and evidence regarding VTE treatment duration.
  • Analysis of risk factors for VTE recurrence and bleeding complications.
  • Consideration of patient-specific factors, including preferences and clinical presentation.

Main Results:

  • Provoked VTE or first unprovoked distal deep vein thrombosis (DVT) typically treated for 3 months due to low recurrence risk.
  • VTE with active cancer or second unprovoked VTE usually requires indefinite anticoagulation due to high recurrence risk.
  • For first unprovoked proximal DVT or pulmonary embolism (PE), treatment duration is balanced by bleeding risk, patient sex, event type (PE vs. DVT), and positive d-dimer testing post-treatment.

Conclusions:

  • The duration of anticoagulation for VTE is a personalized decision.
  • Risk stratification for recurrence and bleeding is paramount in guiding treatment length.
  • Factors such as patient characteristics and specific VTE event details refine the choice between 3-month and indefinite therapy.

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

18.5K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.2K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
756
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
39
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469